Two ASPS member surgeons walk through the breast changes patients may notice after losing weight on GLP-1 drugs, and what to know about them.
Recap by typeshit. Post by Facebook on Facebook.
One study cited by @fittrwithsquats put the risk of non-scarring hair loss about 40% higher with GLP-1 use, mostly telogen effluvium. Nail findings are less consistent.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
ASPS member surgeons Drs. Elise Min and Matthew talk about how GLP-1 weight loss can change the breasts.
Pratt studies the brain circuits behind food motivation and draws on decades of that work to explain what may change when GLP-1 drugs dial cravings down.
Loading…